In SCLC, ATOH1 is associated with tumor-initiating capacity and NE differentiation, initially identified in SCLC cell line-derived xenografts (CDX) and promoting tumor cell survival and metastasis (26, 27). Here, ATOH1 is linked to small cell lung carcinoma.